//
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure
A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report
The year in cardiovascular medicine 2020: heart failure and cardiomyopathies
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial